Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Zuckerman

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancer Research|April 1, 1986
In vitro selection and characterization of a bleomycin-resistant subline of B16 melanomaJ E Zuckerman, T A Raffin, J M Brown, et al.
Anti-Cancer Drug Design|January 1, 1997
Toxicological properties of several novel oligonucleotide analogs in miceS P Henry, J E Zuckerman, J Rojko, et al.
The New England Journal of Medicine|May 23, 1974
Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during sucklingK M Gautvik, A H Tashjian, I A Kourides, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)J M Glover, J M Leeds, T G Mant, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Pharmacokinetic properties of several novel oligonucleotide analogs in miceS T Crooke, M J Graham, J E Zuckerman, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancer Research|April 1, 1986
In vitro selection and characterization of a bleomycin-resistant subline of B16 melanomaJ E Zuckerman, T A Raffin, J M Brown, et al.
Anti-Cancer Drug Design|January 1, 1997
Toxicological properties of several novel oligonucleotide analogs in miceS P Henry, J E Zuckerman, J Rojko, et al.
The New England Journal of Medicine|May 23, 1974
Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during sucklingK M Gautvik, A H Tashjian, I A Kourides, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)J M Glover, J M Leeds, T G Mant, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Pharmacokinetic properties of several novel oligonucleotide analogs in miceS T Crooke, M J Graham, J E Zuckerman, et al.
Pageof 3